Petechiae and a Persistent Violaceous Nodule: A Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm to Dermatology. [PDF]
Anzelc M +3 more
europepmc +1 more source
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]
Khalife-Hachem S +15 more
europepmc +1 more source
Cutaneous Manifestation of a Rare Haematological Malignancy: A Case Report of the Presentation, Diagnosis, and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]
Hassan SL, Chatha DE.
europepmc +1 more source
A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm on the Chest. [PDF]
Tokioka R, Saito-Sasaki N, Sawada Y.
europepmc +1 more source
Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]
Lee BJ.
europepmc +1 more source
Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene. [PDF]
Li R +8 more
europepmc +1 more source
Blastic plasmacytoid dendritic cell neoplasm: Two case reports. [PDF]
Ma YQ, Sun Z, Li YM, Xu H.
europepmc +1 more source
First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial. [PDF]
Stein AS +7 more
europepmc +1 more source
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report of a Rare and Aggressive Hematologic Malignancy. [PDF]
Saha K, Thoram GSK, Roychoudhury S.
europepmc +1 more source

